Boston Scientific Corp. (BSX)

• Annual Data
• Quarterly Data

Boston Scientific Corp., consolidated balance sheet: liabilities and stockholders’ equity

US$ in millions

		Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Current debt obligations
	Accounts payable
	Legal reserves
	Payroll and related liabilities
	Accrued contingent consideration
	Other
	Accrued expenses
	Other current liabilities
	Current liabilities
	Long-term debt
	Deferred income taxes
	Accrued income taxes
	Legal reserves
	Accrued contingent consideration
	Other
	Other long-term liabilities
	Long-term liabilities
	Total liabilities
	Preferred stock, $0.01 par value, none issued and outstanding
	Common stock, $0.01 par value
	Treasury stock, at cost
	Additional paid-in capital
	Accumulated deficit
	Foreign currency translation adjustment
	Unrealized gain (loss) on derivative financial instruments
	Unrealized gain (loss) on available-for-sale securities
	Unrealized costs associated with defined benefit pensions and other items
	Accumulated other comprehensive income (loss), net of tax
	Stockholders’ equity
	Total liabilities and stockholders’ equity

Based on: 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).